Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S
Department of Medicine and Medical Research, University of Leuven, Belgium.
Gut. 1988 May;29(5):631-5. doi: 10.1136/gut.29.5.631.
The effect of the new prokinetic drug cisapride on the resting lower oesophageal sphincter pressure and on the strength of peristaltic contractions was studied in 10 healthy controls and in 10 reflux patients with abnormally low (less than 10 mm Hg) basal lower oesophageal sphincter pressure. A slow intravenous injection of cisapride 10 mg significantly increased the sphincter pressure in the controls but even more in the patients in whom it almost doubled the resting lower oesophageal sphincter pressure of 8.7 (0.5) mm Hg to between 15 and 20 mm Hg for at least 90 min. Results are expressed as mean (SE). Cisapride also significantly increased the amplitude of peristaltic contractions in controls and reflux patients. Therefore, cisapride might be useful in the treatment of reflux.
在10名健康对照者和10名基础下食管括约肌压力异常低(低于10 mmHg)的反流患者中,研究了新型促动力药物西沙必利对静息下食管括约肌压力和蠕动收缩强度的影响。缓慢静脉注射10 mg西沙必利可使对照者的括约肌压力显著升高,但在患者中升高幅度更大,患者静息下食管括约肌压力从8.7(0.5)mmHg几乎翻倍至15至20 mmHg,并至少维持90分钟。结果以均值(标准误)表示。西沙必利还显著增加了对照者和反流患者的蠕动收缩幅度。因此,西沙必利可能对反流治疗有用。